[1]
K HEGAZY, S., A ELBEDEWY, T. and M SAMI, H. 2020. EFFECT OF FENOFIBRATE ADJUVANT THERAPY ON ENDOTHELIAL DYSFUNCTION AND CARDIOVASCULAR RISK IN EGYPTIAN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Asian Journal of Pharmaceutical and Clinical Research. 13, 3 (Mar. 2020), 172–179. DOI:https://doi.org/10.22159/ajpcr.2020.v13i3.36733.